JOIN OUR IN PERSON! LUNCH & LEARN
March 7, 2024 – 11:30 am EST
Title: Feasibility Studies: An efficient and effective means of reducing risk during AAV therapy development
Join us as we discuss FUJIFILM Diosynth Biotechnologies’ techniques to implement, optimize and develop
robust processes and analytical tools to measure potency, safety, quality, and consistency of gene therapy
products. We will explore the benefits of early-stage feasibility studies and development for gene therapy
products going to market that will pass the scrutiny of the FDA and other regulatory agencies.
• Platform feasibility
• Critical Quality Attributes
• Suitability for GMP Environments
Punam Ghosh, Ph.D.
Senior Scientist – Analytical Process Development
Process Development Scientist II
Lunch will be provided.